Try our beta test site

Nivestim™ in Treatment of Malignant Diseases

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hospira, Inc.
ClinicalTrials.gov Identifier:
NCT01627990
First received: June 7, 2012
Last updated: July 23, 2015
Last verified: July 2015